All proceeded as per the original plan. A month and a half later, Anderes, which had secured investments from thirteen financial magnate groups and had raised a total of 65 billion US dollars, received immense momentum.
Under the capital injection of these thirteen financial magnate groups, as well as governmental policy protection and assistance, the remaining multinational pharmaceutical monopolies had no way to openly obstruct or engage in malicious competition. They could only watch as Anderes grew stronger and inevitably became a burgeoning global biotech corporation.
Though Anderes may be inferior to these century-old pharmaceutical corporations in terms of overall capital, it certainly did not fall short in controlling cash flow.
In total, Anderes, with more than 80 billion US dollars in cash reserves, would instantly become one of the world's "wealthiest" companies, owning half of the cash of Apple Company, if this cash could be publicly disclosed.
